Advertisement

Multimodal Production of Adeno-Associated Virus

  • Ivette M. SandovalEmail author
  • Nathan M. Kuhn
  • Fredric P. Manfredsson
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1937)

Abstract

Adeno-associated virus (AAV) is an increasingly popular tool in the research laboratory, and use of this viral vector clinically is occurring at an accelerated pace. Nevertheless, despite its popularity, AAV is a relatively cumbersome virus to produce; however, significant efforts have been invested to develop, optimize, and simplify methodology that allows the generation of high-quality AAV with significantly increased production yields. Here we describe multiple modalities for production and purification of AAV particles produced in HEK293 cell cultures using an iodixanol density gradient. We include two methods adapted for harvesting virus from the culture media: tangential flow filtration (TFF) and polyethylene glycol precipitation (PEGylation). Moreover, we also describe the protocol for anion exchange chromatography, which can be used after the iodixanol gradient as an additional purification step. Last, we provide various protocols for determining virus titer.

Key words

AAV AAV production Iodixanol gradient Tangential flow filtration PEGylation Digital droplet PCR 

Notes

Acknowledgments

The methodology outlined herein represents the accumulated knowledge accrued over years of trial and error, and could not be possible without the help of countless people. We would especially like to recognize: Mark Potter, Vince Chiodo, Shannon Boye, and Sanford Boye at the University of Florida. Kevin Nash at the University of South Florida.

References

  1. 1.
    Manfredsson FP (2016) Introduction to viral vectors and other delivery methods for gene therapy of the nervous system. Methods Mol Biol 1382:3–18CrossRefGoogle Scholar
  2. 2.
    Kondratov O, Marsic D, Crosson SM et al (2017) Direct head-to-head evaluation of recombinant adeno-associated viral vectors manufactured in human versus insect cells. Mol Ther 25:2661–2675CrossRefGoogle Scholar
  3. 3.
    Urabe M, Ding C, Kotin RM (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13:1935–1943CrossRefGoogle Scholar
  4. 4.
    Strobel B, Miller FD, Rist W et al (2015) Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications. Hum Gene Ther Methods 26:147–157CrossRefGoogle Scholar
  5. 5.
    Modak SP, Imaizumi MT, Chappuis M et al (1978) Preparative density gradient centrifugation of RNA and DNA in cesium sulfate-urea mixture. Mol Biol Rep 4:55–60CrossRefGoogle Scholar
  6. 6.
    Nilsen TW (2013) RNA-friendly plasmid preparation. Cold Spring Harb Protoc 2013:174–179PubMedGoogle Scholar
  7. 7.
    Heilig JS, Elbing KL, Brent R (2001) Large-scale preparation of plasmid DNA. Curr Protoc Mol Biol Chapter 1:Unit1 7PubMedGoogle Scholar
  8. 8.
    Burger C, Nash KR (2016) Small-scale recombinant adeno-associated virus purification. Methods Mol Biol 1382:95–106CrossRefGoogle Scholar
  9. 9.
    Benskey MJ, Sandoval IM, Manfredsson FP (2016) Continuous collection of adeno-associated virus from producer cell medium significantly increases total viral yield. Hum Gene Ther Methods 27:32–45CrossRefGoogle Scholar
  10. 10.
    Benskey MJ, Manfredsson FP (2016) Intraparenchymal stereotaxic delivery of rAAV and special considerations in vector handling. Methods Mol Biol 1382:199–215CrossRefGoogle Scholar
  11. 11.
    Nass SA, Mattingly MA, Woodcock DA et al (2018) Universal method for the purification of recombinant AAV vectors of differing serotypes. Mol Ther Methods Clin Dev 9:33–46CrossRefGoogle Scholar
  12. 12.
    Potter M, Lins B, Mietzsch M et al (2014) A simplified purification protocol for recombinant adeno-associated virus vectors. Mol Ther Methods Clin Dev 1:14034CrossRefGoogle Scholar
  13. 13.
    Qu W, Wang M, Wu Y et al (2015) Scalable downstream strategies for purification of recombinant adeno-associated virus vectors in light of the properties. Curr Pharm Biotechnol 16:684–695CrossRefGoogle Scholar
  14. 14.
    Fischer MD, Hickey DG, Singh MS et al (2016) Evaluation of an optimized injection system for retinal gene therapy in human patients. Hum Gene Ther Methods 27:150–158CrossRefGoogle Scholar
  15. 15.
    Zolotukhin S, Potter M, Zolotukhin I et al (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158–167CrossRefGoogle Scholar
  16. 16.
    Sanders R, Huggett JF, Bushell CA et al (2011) Evaluation of digital PCR for absolute DNA quantification. Anal Chem 83:6474–6484CrossRefGoogle Scholar
  17. 17.
    Lock M, Alvira MR, Chen SJ et al (2014) Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. Hum Gene Ther Methods 25:115–125CrossRefGoogle Scholar
  18. 18.
    Ayuso E, Blouin V, Lock M et al (2014) Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Hum Gene Ther 25:977–987CrossRefGoogle Scholar
  19. 19.
    Lock M, McGorray S, Auricchio A et al (2010) Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther 21:1273–1285CrossRefGoogle Scholar
  20. 20.
    Benskey MJ, Kuhn NC, Galligan JJ et al (2015) Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants. Mol Ther 23:488–500CrossRefGoogle Scholar
  21. 21.
    Guo P, El-Gohary Y, Prasadan K et al (2012) Rapid and simplified purification of recombinant adeno-associated virus. J Virol Methods 183:139–146CrossRefGoogle Scholar
  22. 22.
    Boye SL, Bennett A, Scalabrino ML et al (2016) Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors. J Virol 90:4215–4231CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ivette M. Sandoval
    • 1
    • 2
    Email author
  • Nathan M. Kuhn
    • 1
  • Fredric P. Manfredsson
    • 1
    • 2
  1. 1.Department of Translational Science & Molecular MedicineMichigan State UniversityGrand RapidsUSA
  2. 2.Mercy Health Saint Mary’sGrand RapidsUSA

Personalised recommendations